Inicio>>Lipids>> Sphingolipids>>2-Acetyl-5-tetrahydroxybutyl Imidazole

2-Acetyl-5-tetrahydroxybutyl Imidazole (Synonyms: 2-Acetyl-4-tetrahydroxybutyl Imidazole, 2-ATHBI, THI)

Catalog No.GC42112

Sphingosine-1-phosphate (S1P) lyase catalyzes the irreversible decomposition of S1P to hexadecanaldehyde and phosphoethanolamine.

Products are for research use only. Not for human use. We do not sell to patients.

2-Acetyl-5-tetrahydroxybutyl Imidazole Chemical Structure

Cas No.: 94944-70-4

Tamaño Precio Disponibilidad Cantidad
500μg
88,00 $
Disponible
1mg
167,00 $
Disponible
5mg
699,00 $
Disponible
10mg
1.224,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Sphingosine-1-phosphate (S1P) lyase catalyzes the irreversible decomposition of S1P to hexadecanaldehyde and phosphoethanolamine. 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) is an inhibitor of S1P lyase. Because S1P lyase is primarily expressed in lymphatic tissue, treatment of mice with THI (50 µg/ml in drinking water) increases lymphoid tissue S1P concentrations 100-fold, reducing lymphocyte egress from thymus and peripheral lymphoid organs. The resulting lymphopenia is reversible following cessation of THI treatment. Reducing S1P lyase activity results in therapeutic levels of immunosuppression without the non-lymphoid lesions that result from synthetic S1P receptor agonists.

Reseñas

Review for 2-Acetyl-5-tetrahydroxybutyl Imidazole

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2-Acetyl-5-tetrahydroxybutyl Imidazole

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.